Pilot study of levodopa dose as treatment for residual amblyopia in children aged 8 years to younger than 18 years

Arch Ophthalmol. 2010 Sep;128(9):1215-7. doi: 10.1001/archophthalmol.2010.178.
No abstract available

Publication types

  • Clinical Trial, Phase III
  • Comparative Study
  • Letter
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Amblyopia / drug therapy*
  • Amblyopia / physiopathology
  • Child
  • Dopamine Agents / administration & dosage*
  • Female
  • Follow-Up Studies
  • Humans
  • Levodopa / administration & dosage*
  • Male
  • Pilot Projects
  • Prospective Studies
  • Visual Acuity / physiology

Substances

  • Dopamine Agents
  • Levodopa